TheProfitWatch

LENZ - LENZ Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
39.35 2.18 (5.54%) --- --- --- 0.15 (0.38%) 2.6 (6.62%) -0.01 (-0.02%) -0.01 (-0.02%)

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.53
Diluted EPS:
-0.53
Basic P/E:
-78.3585
Diluted P/E:
-78.3585
RSI(14) 1m:
0.0
VWAP:
41.53
RVol:
1.1681

Events

Period Kind Movement Occurred At
1m Price increase 1m 39.96 +0.7 (+1.8%) Oct 15 09:32

Related News